Effects of Stevia on Satiety and Eating Attitudes in Healthy, Overweight and Obese Adults

NCT ID: NCT01115088

Last Updated: 2016-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effects that three different types of sweeteners have on food intake, hunger and satiety levels, as well as insulin and glucose measures. The study of whether food or beverages containing Stevia influence food intake to a greater extent than food or beverages sweetened with Aspartame or Sucrose. Also, examining whether taste preference and taste sensitivity influence food intake.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Expected time in this study will be approximately 24 hours spread over the course of one initial screening visit and three test days during which you complete food tests at the Pennington Center.

Screening visit (Duration is 3 hours)

* You will initially be asked to fill out psychological questionnaires to assess your eating habits, food cravings, and preference for foods (i.e., tea and crackers with cream cheese) that will be provided to you in this study.
* You will also be asked to complete two taste tests during this visit. The first taste test will be sodium chloride (table salt) followed by PROP (an extremely low dose of hyperthyroid medication) sodium chloride (table salt).
* You will be required to provide a blood sample (19 mL or 1.3 tablespoons) to check glucose and insulin levels.
* If you are selected to be a participant for this study, you will receive a brief medical evaluation during which you will be weighed, your height will be measured, and your pulse and blood pressure will be taken. You will be interviewed about your medical history and potential obstacles for completing the study. If you are female, a brief interview will be conducted to determine your menstrual cycle phase. Total length of time will be approximately three hours for the screening visit.

First Food Test Day (Duration is 7- 9 hours. You'll arrive after having fasted for 12 hrs.) For females, all test meal days will be scheduled during their luteal phase. • Breakfast: During your first food test day, you will be asked to come to the Pennington Center at any time between the hours of 7:00 A.M. - 8:30 A.M. and consume a standard breakfast of Cheerios, milk, orange juice, toast, butter, and jelly. You will then be free to leave but will be asked to return 3.5 hours later. When your return, you will be sent to our inpatient unit for a blood draw, which will test your level of insulin and glucose (total of 25 mL or 1.67 tablespoons). You will then be asked to rate your appetite on a computer using a visual analog scale (VAS). After completing these VAS ratings, you will be provided with an appetizer of 5 ounces of cold tea and 6 crackers with cream cheese. Both the tea and the cream cheese will be sweetened with one of the following sweeteners: Aspartame, Sucrose, or Stevia. After consuming this appetizer, you will be asked to complete another set of VAS ratings, which again ask you about your appetite, as well as the sweetness of the appetizer. Test times will be constant for all visits. Approximately twenty minutes after consuming this appetizer, your insulin and glucose levels will again be tested and you will complete another set of VAS ratings before your lunch meal. You will be required to consume breakfast at the same time for all three visits. For example, if you come at 7:00 A.M. on your first test day, you will be required to come in at 7:00 A.M. on your next two test days.

• Lunch: After completing VAS ratings before lunch, you will be provided with a lunch consisting of sandwiches, chips, and cookies. Your lunch meal will be served approximately 4 hours after your breakfast meal. Your eating behavior may be monitored by weight of the food consumed and/or by video camera/tape. You may eat as much or as little of the lunch as you wish.

• After Lunch: After you finish your lunch meal, you will be asked to complete post meal VAS ratings. Your insulin and glucose will be measured on the three occasions after lunch: 30 minutes after lunch, one hour after lunch, and two hours after lunch for a total of 5 blood draws (total of 25 mL or 1.67 tablespoons). You will also be asked to complete VAS ratings 30 minutes after lunch, and every hour for the next four hours. You will spend the afternoon at the Pennington center to ensure that blood draws and VAS ratings occur at the appropriate time intervals. During the afternoon you will be free to read, do paperwork brought from home or work, or watch movies that will be provided to you by the Center.

• Dinner:

Four hours after the test lunch, you will be provided with another appetizer of 5 ounces of cold tea and crackers with cream cheese. Both the tea and the cream cheese will be sweetened with one of the following sweeteners: Stevia, sucrose, or Aspartame. You will complete VAS ratings before and after this appetizer, as well as before and after your dinner meal (4.5 hours after lunch), during which you will be instructed to eat as much or as little of any of the items presented as you want. Your eating behavior may be monitored by weight of the food consumed and/or by video camera/tape. After you complete VAS questions after the evening meal, you will have fulfilled the requirements of the first food test day. However, you will be asked not to consume any food or caloric beverages for three hours following your dinner meal. You will be asked to report any adverse events from this day at this visit.

Second Food Test Day (Duration is 7-9 hours. You'll arrive after having fasted for 12 hrs.) • On your second food test day, you will complete the same procedures and meal tests as you did during the first food test day. However, the type of sweetener used in your tea and crackers with cream cheese will differ from the type of sweetener you received on your first food test day. You will be asked to report any adverse events from this day, as well as previous visits, at this visit.

Third Food Test Day (Duration is 7-9 hours. You'll arrive after having fasted for 12 hrs.)

• On your third food test day, you will complete the same procedures and meal tests as you did during your two previous food test days. However, the type of sweetener used in your tea and crackers with cream cheese will differ from the type of sweetener you received on previous visits. You will also be asked to report any adverse events from this day, as well as previous visits, at this visit. We will also follow up by phone regarding adverse events following your third visit. Table 1 presents a schedule of the procedures that will take place at each of the study visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aspartame

Food or beverages containing Aspartame in comparison to Stevia or Sucrose

Group Type EXPERIMENTAL

Aspartame

Intervention Type DIETARY_SUPPLEMENT

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Sucrose

Food or beverages containing Sucrose in comparison to Aspartame or Stevia

Group Type EXPERIMENTAL

Sucrose

Intervention Type DIETARY_SUPPLEMENT

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Stevia

Food or beverages containing Stevia in comparison to Aspartame or Sucrose

Group Type EXPERIMENTAL

Stevia

Intervention Type DIETARY_SUPPLEMENT

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aspartame

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Intervention Type DIETARY_SUPPLEMENT

Sucrose

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Intervention Type DIETARY_SUPPLEMENT

Stevia

The morning breakfast after a 12-h fast and consumed a standard 469 kcal breakfast consisting of cereal, milk, toast with butter, and orange juice. Tea and crackers with cream cheese sweetened with stevia Whole Foods 365 Brand, aspartame equal sweetener, or sucrose participants consumed this preload 20 min before their test lunch and dinner meals. The Test lunch meal consisted of sandwiches, potato chips, and cookies, and the test dinner meal was a self-selected buffet-type meal (I.e., Macronutrient Self-Selection Paradigm) Geiselman et al,. 1998)

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

equal sweetener

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy and have a body mass index \> 30 kg/m2 and \< 39.9 kg/m2, or have a body mass index \> 20 kg/m2 and \< 24.9 kg/m2
* If BMI is between 30 and 39.9, waist circumference must be \> 36 for women and \> 40 for men.
* Age 18 to 45 years
* Nonsmokers
* Willing to consume meat products
* Women on monophasic oral contraceptives or who have physiologically controlled cycles

Exclusion Criteria

* A history of diabetes, cardiovascular disease, or other chronic illnesses
* Presence of an eating disorder including Anorexia and/or Bulimia Nervosa
* Other health problems that might interfere with your ability to participate in the study
* Taking medications, other than monophasic birth control or monophasic (same dose every day) hormone replacement therapy and allergy medication
* Taking allergy medication for a period of time less than 6 months
* Dislike of or allergy to foods/sweeteners (Sucrose, Stevia, or Aspartame) used in test meals
* Smokers
* High scores on the Dietary Restraint, Disinhibition, and Perceived Hunger scales of the Three Factor Eating Questionnaire
* Use of oral contraceptives other than monophasic (same dose every day) contraceptives
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pennington Biomedical Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

William Cefalu, MD

Executive Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephen D. Anton, PhD

Role: PRINCIPAL_INVESTIGATOR

Pennington Biomedical Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBRC 25030

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabolic Effects of Non-Nutritive Sweeteners
NCT01200940 COMPLETED PHASE1/PHASE2